{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:00:11Z","timestamp":1791316811805,"version":"4.3.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      Metoclopramide and domperidone are prokinetic and antiemetic substances often used in clinical practice. Although domperidone has a more favorable side effect profile and is considered the first-line agent, severe cardiac side effects were reported during the administration of both substances. Cardiac Na\n                      <jats:sup>+<\/jats:sup>\n                      channels are common targets of therapeutics inducing cardiotoxicity. Therefore, the aim of this study was to investigate whether the differential cardiotoxicities of metoclopramide and domperidone correlate with the block of Na\n                      <jats:sup>+<\/jats:sup>\n                      channels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Effects of metoclopramide and domperidone on the human \u03b1-subunit Nav1.5 expressed in human embryonic kidney 293 cells and on Na\n                      <jats:sup>+<\/jats:sup>\n                      currents in neonatal rat cardiomyocytes were investigated by means of whole-cell patch clamp recordings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Tonic block of resting Nav1.5 channels was more potent for domperidone (IC\n                      <jats:sub>50<\/jats:sub>\n                      85 \u00b1 25 \u03bcM; 95% confidence interval [CI], 36\u2013134) compared with metoclopramide (IC\n                      <jats:sub>50<\/jats:sub>\n                      458 \u00b1 28 \u03bcM; 95% CI, 403\u2013513). Both agents induced use-dependent block at 10 and 1 Hz, stabilized fast and slow inactivation, and delayed recovery from inactivation. However, metoclopramide induced considerably smaller effects compared with domperidone. Na\n                      <jats:sup>+<\/jats:sup>\n                      currents in rat cardiomyocytes displayed tonic and use-dependent block by both substances, and in this system, domperidone (IC\n                      <jats:sub>50<\/jats:sub>\n                      312 \u00b1 15 \u03bcM; 95% CI, 22\u2013602) and metoclopramide (IC\n                      <jats:sub>50<\/jats:sub>\n                      250 \u00b1 30 \u03bcM; 95% CI, 191\u2013309) induced a similar degree of tonic block.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      Our data demonstrate that the clinically relevant cardiotoxicity of domperidone and metoclopramide corresponds to a rather potent and local anesthetic-like inhibition of cardiac Na\n                      <jats:sup>+<\/jats:sup>\n                      channels including Nav1.5. These data suggest that Nav1.5 might be a hitherto unrecognized molecular mechanism of some cardiovascular side effects, for example, malignant arrhythmias of prokinetic and antiemetic agents.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000001673","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T19:53:12Z","timestamp":1479412392000},"page":"52-60","source":"Crossref","is-referenced-by-count":15,"title":["Cardiotoxic Antiemetics Metoclopramide and Domperidone Block Cardiac Voltage-Gated Na+ Channels"],"prefix":"10.1213","volume":"124","author":[{"given":"Carsten","family":"Stoetzer","sequence":"first","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Voelker","sequence":"additional","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorben","family":"Doll","sequence":"additional","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Heineke","sequence":"additional","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wegner","sequence":"additional","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leffler","sequence":"additional","affiliation":[{"name":"Neurology, Hannover Medical School, Hannover, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMcp062614","article-title":"Clinical practice. Diabetic gastroparesis.","volume":"356","author":"Camilleri","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11894-012-0275-3","article-title":"Prokinetics in diabetic gastroparesis.","volume":"14","author":"Hejazi","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/14740338.2014.851193","article-title":"Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactagogue medicine.","volume":"13","author":"Doggrell","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000083234","article-title":"Comparison of the effects of metoclopramide and domperidone on HERG channels.","volume":"74","author":"Claassen","year":"2005","journal-title":"Pharmacology"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ajg.2012.300","article-title":"The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits.","volume":"108","author":"Ehrenpreis","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4212\/cjhp.v67i6.1407","article-title":"Domperidone-associated sudden cardiac death in the general population and implications for use in patients undergoing hemodialysis: a literature review.","volume":"67","author":"Makari","year":"2014","journal-title":"Can J Hosp Pharm"},{"key":"R7-20230812","first-page":"805","article-title":"Torsade de pointes induced by metoclopramide in an elderly woman with preexisting complete left bundle branch block.","volume":"24","author":"Chou","year":"2001","journal-title":"Chang Gung Med J"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1034\/j.1399-6576.2002.460725.x","article-title":"Cardiac arrest after intravenous metoclopramide\u2014a case of five repeated injections of metoclopramide causing five episodes of cardiac arrest.","volume":"46","author":"Bentsen","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0140-6736(84)92931-3","article-title":"Sudden death after acute dystonic reaction to high-dose metoclopramide.","volume":"2","author":"Pollera","year":"1984","journal-title":"Lancet"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2036.2003.01641.x","article-title":"The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers.","volume":"18","author":"Ellidokuz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/157488610791698334","article-title":"Domperidone and long QT syndrome.","volume":"5","author":"Rossi","year":"2010","journal-title":"Curr Drug Saf"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(82)92016-5","article-title":"Sudden death in cancer patient on high-dose domperidone.","volume":"1","author":"Joss","year":"1982","journal-title":"Lancet"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.289.6458.1579","article-title":"Cardiac arrest after treatment with intravenous domperidone.","volume":"289","author":"Roussak","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(84)90841-9","article-title":"Two sudden deaths during prophylactic antiemetic treatment with high doses of domperidone and methylprednisolone.","volume":"2","author":"Giaccone","year":"1984","journal-title":"Lancet"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(85)92515-2","article-title":"Cardiotoxicity of intravenous domperidone.","volume":"2","author":"Osborne","year":"1985","journal-title":"Lancet"},{"key":"R16-20230812","first-page":"545","article-title":"Q-T interval prolongation and ventricular fibrillation with i.v. domperidone.","volume":"70","author":"Bruera","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00588359","article-title":"Cardiac membrane currents as affected by an neuroleptic agent: droperidol.","volume":"325","author":"Kern","year":"1971","journal-title":"Pflugers Arch"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00498871","article-title":"Electrophysiological effects of droperidol in different cardiac tissues.","volume":"293","author":"Carmeliet","year":"1976","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1213\/ANE.0000000000000646","article-title":"A comparative analysis of bupivacaine and ropivacaine effects on human cardiac SCN5A channels.","volume":"120","author":"Schwoerer","year":"2015","journal-title":"Anesth Analg"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/pr.55.4.7","article-title":"International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels.","volume":"55","author":"Catterall","year":"2003","journal-title":"Pharmacol Rev"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12630-010-9275-7","article-title":"Local anesthetic systemic toxicity.","volume":"57","author":"Dillane","year":"2010","journal-title":"Can J Anaesth"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00000542-199004000-00022","article-title":"Molecular mechanisms of local anesthesia: a review.","volume":"72","author":"Butterworth","year":"1990","journal-title":"Anesthesiology"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1073\/pnas.0405488102","article-title":"Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc.","volume":"102","author":"Heineke","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00000542-198504000-00006","article-title":"Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole.","volume":"62","author":"Clarkson","year":"1985","journal-title":"Anesthesiology"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00000542-200010000-00026","article-title":"Block of human heart hH1 sodium channels by the enantiomers of bupivacaine.","volume":"93","author":"Nau","year":"2000","journal-title":"Anesthesiology"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bph.12465","article-title":"The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na+ channel, Na(v)1.5.","volume":"171","author":"Schulze","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.4081\/cp.2011.e83","article-title":"Metoclopramide-induced cardiac arrest.","volume":"1","author":"Rumore","year":"2011","journal-title":"Clin Pract"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/01.CIR.102.16.1883","article-title":"Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders.","volume":"102","author":"Drolet","year":"2000","journal-title":"Circulation"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00542101","article-title":"Single-dose pharmacokinetics of metoclopramide.","volume":"20","author":"Ross-Lee","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10620-010-1472-2","article-title":"Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.","volume":"56","author":"Parkman","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R31-20230812","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.pnpbp.2009.04.023","article-title":"Dosing of antipsychotics in schizophrenia across the life-spectrum.","volume":"33","author":"Uchida","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R32-20230812","first-page":"1013","article-title":"Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone. Xenobiotica.","volume":"34","author":"Simard","year":"2004"},{"key":"R33-20230812","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM198107023050106","volume":"305","author":"Schulze-Delrieu","year":"1981","journal-title":"Drug therapy. Metoclopramide. N Engl J Med."},{"key":"R34-20230812","first-page":"381","article-title":"Sinus arrest after administration of intravenous metoclopramide. Ann Pharmacother.","volume":"29","author":"Malkoff","year":"1995"},{"key":"R35-20230812","first-page":"261","article-title":"Functional protein expression of multiple Na+ channel alpha- and beta-subunit isoforms in neonatal cardiomyocytes. J Mol Cell Cardiol.","volume":"48","author":"Kaufmann","year":"2010"},{"key":"R36-20230812","first-page":"1421","article-title":"Distinct subcellular localization of different Na+ channel alpha and beta subunits in single ventricular myocytes from mouse heart. Circulation.","volume":"109","author":"Maier","year":"2004"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201701000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:49Z","timestamp":1786112869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201701000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000001673","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}